Roche

New Leukemia Drugs Bring Chemotherapy-Free Treatment Potential
Bloomberg
Mon, 12/9/13 - 08:38 am
Gilead Sciences
Roche
Pharmacyclics
CLL
chronic lymphocytic leukemia
Breast Cancer Drug Data Boosts Puma Biotechnology
Investors.com
Thu, 12/5/13 - 12:01 pm
Puma Biotechnology
breast cancer
neratinib
Taxol
Bristol-Myers Squibb
Roche
Herceptin
Ditching Big Drugmakers for Biotech Brings Leukemia Boon
Bloomberg
Thu, 12/5/13 - 08:26 am
chronic lymphocytic leukemia
Gilead
Pharmacyclics
CLL
Roche
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Bristol-Myers Squibb
GSK
JNJ
Ophthotech
Novartis
Regeneron
Roche
Sanofi
Roche teams with Molecular Partners on armed proteins in $1B-plus deal
Fierce Biotech
Wed, 12/4/13 - 10:18 am
Roche
Molecular Partners
DARPin
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Seeking Alpha
Tue, 12/3/13 - 11:04 am
pSivida
ophthalmology
GSK
Novartis
Pfizer
Regeneron
Roche
Sanofi
Iluvien
Durasert
Medidur
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals
The Race For A Cure For Cancer
Seeking Alpha
Thu, 11/21/13 - 12:09 pm
cancer
Merck
Bristol-Myers Squibb
Roche
Peregrine Pharmaceuticals
EU backs Roche’s Kadycla in breast cancer
PM Live
Wed, 11/20/13 - 08:33 am
Europe
Roche
Kadcyla
breast cancer
Small Esperion Vs Pharma Giants In The Cholesterol Race
Seeking Alpha
Mon, 11/11/13 - 10:35 am
Esperion Therapeutics
ETC-1002
Sanofi
Regeneron
Amgen
Pfizer
Roche
New Roche leukemia drug shows clear advantage over Rituxan-study
Yahoo/Reuters
Thu, 11/7/13 - 09:47 am
Roche
Rituxan
GA101
Gazyva
Roche Pacing the Field in the Biotech Race
TheStreet.com
Wed, 11/6/13 - 08:20 am
Roche
Amgen
Gilead
Sanofi
Celgene
Roche's Gazyva Approval Marks Success in Oncology and New FDA Designation
Motley Fool
Tue, 11/5/13 - 03:55 pm
Roche
Gazyva
FDA
CLL
chronic lymphocytic leukemia
Roche to Pay Up to $548 Million for ‘Superbug’ Antibiotic
Bloomberg
Mon, 11/4/13 - 10:01 am
Roche
antibiotics
superbugs
POL7080
Polyphor
Merck: Why Oncology Smells Like Money
Seeking Alpha
Mon, 11/4/13 - 09:49 am
Merck
oncology
Roche
Bristol-Myers Squibb
MK-3475
melanoma
FDA approves Roche leukemia drug Gazyva
Reuters
Fri, 11/1/13 - 11:48 am
FDA
Roche
Gazyva
chronic lymphocytic leukemia
CLL
New two-hormone Roche drug shows promise in diabetes, obesity
Reuters
Thu, 10/31/13 - 11:29 am
Roche
obesity
diabetes
GLP-1 agonist
Partnerships Have Been a Boost for Inovio
Motley Fool
Fri, 10/25/13 - 09:59 am
Inovio
Roche
Samsung, Roche in biologics manufacturing deal
Biocentury
Wed, 10/23/13 - 10:13 am
Samsung
Roche
biologics
Roche CEO would not exclude move into rare diseases
Yahoo/Reuters
Wed, 10/23/13 - 09:42 am
Roche
Severin Schwan
Pharma CEOs

Pages